Pure Global AI
Registration holder profile

FUNDACAO OSWALDO CRUZ

Brazil44 ANVISA registrations24 unique technical categoriesOct 29, 2004 – Mar 23, 2026
Verified
44
Total products
24
Technical names
Oct 2004
Earliest registration
Mar 2026
Latest registration
Regulatory footprint
Search FUNDACAO OSWALDO CRUZ across other regulatory registries
ThailandEuropean UnionVietnamSouth KoreaEcuadorUnited States
Recent registrations
Latest 5 products registered by this holder
LEPTOSPIRA SP
TR Leptospirose IgG/IgM Bio-Manguinhos
Class III · Mar 23, 2026
Needle-free drug/vaccine injector, mechanical
Caneta para Insulina Bio-Manguinhos
Class II · Mar 09, 2026
ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND HIV 2)
TR HIV 1/2 - BIO-MANGUINHOS
Class IV · Jul 28, 2025
HANTAVIRUS
TR Hantavírus IgM Bio-Manguinhos
Class III · Apr 07, 2025
DENGUE
TR DENGUE NS1 Ag BIO-MANGUINHOS
Class III · Mar 24, 2025
Most popular products
Products with most registrations
CORONAVIRUS
5 registrations
ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND HIV 2)
4 registrations
DENGUE
4 registrations
COMBINED PARAMETERS - RESPIRATORY PANEL
3 registrations
PLASMODIUM
2 registrations
Top manufacturers
Manufacturers with the most products registered by this holder
FUNDAÇÃO OSWALDO CRUZ
31 products
Fundação Oswaldo Cruz - Instituto de Tecnologia em Imunobiológicos -
10 products
GANGAN MEDICAL TECHNOLOGY JIANGSU CO., LTD
1 products
CHEMBIO DIAGNOSTIC SYSTEMS, INC.
1 products
Fundação Oswaldo Cruz
1 products
Products per risk level
Distribution of distinct commercial products by ANVISA risk classification
Class I2Distinct Products · 2 total registrations
Class II2Distinct Products · 2 total registrations
Class III23Distinct Products · 23 total registrations
Class IV17Distinct Products · 17 total registrations
About this profile

Access comprehensive registration holder profile for FUNDACAO OSWALDO CRUZ through Pure Global AI's free Brazil medical device database. This registration holder manages 44 medical device registrations with ANVISA across 24 unique technical categories. Their regulatory portfolio spans from Oct 29, 2004 to Mar 23, 2026.

This page provides comprehensive insights including 5 recent product registrations with the latest being LEPTOSPIRA SP (TR Leptospirose IgG/IgM Bio-Manguinhos), 5 most popular products led by CORONAVIRUS with 5 registrations, partnerships with 5 key manufacturers including FUNDAÇÃO OSWALDO CRUZ and Fundação Oswaldo Cruz - Instituto de Tecnologia em Imunobiológicos -, and products across 4 risk classifications with 2 Class I devices. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping distributors understand market dynamics and identify business opportunities.